Researchers reported on patient acceptance of an e-consent tool for asynchronous delivery of study information and for receiving consent from patients.

Interim safety and efficacy data to be reported in Q1VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Processa ...

MSU players focused on being a pro's pro during Christmas break, all while the NCAA allows pros to play college ball to the ...

A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic makeup, with an increasing trend of trials underrepresenting Black and ...

More than 20 new California workplace laws take effect this year, including one that could rewrite the rules on bonuses, ...

The FLAMINGO-01 DSMB met twice in 2025, most recently in December 2025, and recommended to continue the study as is without modification. The Steering Committee also met at SABCS 2025 and discussed ...

Detailed price information for Promis Neurosciences Inc (PMN-Q) from The Globe and Mail including charting and trades.

Unless such surprises materialize, analysts like Phipps see the Dynavax story as largely written, with most of the remaining upside and downside bounded by Sanofi’s $15.50 per share offer. Inhibikase ...

The FLAMINGO-01 DSMB met twice in 2025, most recently in December 2025, and recommended to continue the study as is without modification. The Steering Committee also met at SABCS 2025 and discussed ...

Objectives: to analyze maternal choices regarding child care from pregnancy to the child’s first year of life. Methods: prospective and quantitative longitudinal study developed in three stages ...

Barnes & Noble Education trades at under 4x EBITDA with 1.3x net-debt-to-EBITDA and positive net income. See why I rate BNED ...

More people than ever are entering medical school, and with the number of applicants increasing, it is harder to get in.